A drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE).
JAMM Therapeutics is a pioneering biotechnology research company dedicated to the discovery and development of innovative small molecule modulators. With a focus on systemic lupus erythematosus (SLE), JAMM Therapeutics is committed to advancing therapeutic solutions that improve patient outcomes and enhance the quality of life for those affected by this challenging condition. Located at Ilan Ramon 2, Ness Ziona, IL, JAMM Therapeutics leverages cutting-edge research and development to address unmet medical needs.
At JAMM Therapeutics, the mission is to translate scientific breakthroughs into effective treatments. The company's team of experts is dedicated to exploring novel approaches and refining existing technologies to create targeted therapies. JAMM Therapeutics aims to be at the forefront of medical innovation, driving progress in the treatment of SLE and related autoimmune diseases.
JAMM Therapeutics is actively expanding its research initiatives and welcomes opportunities for collaboration and partnership. With a forward-looking vision, JAMM Therapeutics is poised to make a significant impact on the future of healthcare. We invite the management team at JAMM Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further amplify your market presence.
Other organizations in the same industry
This company is also known as